z-logo
Premium
The impact of an appointment‐based medication synchronization programme on chronic medication adherence in an adult community pharmacy population
Author(s) -
Andrews S. B.,
Marcy T. R.,
Osborn B.,
Planas L. G.
Publication year - 2017
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12533
Subject(s) - pharmacy , community pharmacy , medication adherence , medicine , family medicine , population , clinical pharmacy , environmental health
Summary What is known and objectives Non‐adherence to medication regimens is the primary cause of suboptimal clinical benefit in patients with chronic diseases. The primary objective of this study was to assess and compare adherence to chronic medications among adults participating in Time My Meds ( TMM ), an appointment‐based medication synchronization programme, to patients receiving usual care. Methods This was a quasi‐experimental study that evaluated data from 18 partner community pharmacies in three lower U.S. Midwestern states between January 2013 and May 2015. Results During the 6‐month post‐period, PDC ≥0.80 was achieved by 73.53%, 80.41% and 75.00% of usual care patients taking oral diabetes, renin‐angiotensin system antagonist ( RASA ) and statin medications. In comparison, the PDC threshold was achieved by 100%, 97.94% and 97.62% of TMM patients taking oral diabetes, RASA and statin medications ( P <.031 in diabetes group and P <.003 in RASA group). The percentage of on‐time prescription refills increased from 69.68% to 84.75% in patients with diabetes, 79.04% to 89.56% in the hypertension group and 78.26% to 89.07% in the hyperlipidaemic group. What is new and conclusion An appointment‐based medication synchronization programme in community pharmacies resulted in improved adherence and increased percentage of on‐time refills.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here